CagriSema Dual-Pathway Metabolic Signaling Compound CagriSema combines two investigational molecules Cagrilintide (amylin analogue) and Semaglutide (GLP-1 receptor agonist), designed to influence key metabolic and appetite-regulating pathways. Current US$ 27.09 Min. order: 1 piece ★★★★★ 4.2 (198 reviews) Sold : Login>>
Structural and mechanistic insights into dual activation of cagrilintide in amylin and calcitonin receptors US$ 21.53 Min. order: 1 piece ★★★★★ 4.8 (18 reviews) Sold : Login>>
Cagrilintide: The Next-Gen Peptide for Weight Loss and Satiety US$ 29.87 Min. order: 1 piece ★★★★★ 4.2 (292 reviews) Sold : Login>>
Clinical trials of subcutaneous tirzepatide, retatrutide, and US$ 25.48 Min. order: 1 piece ★★★★★ 4.4 (23 reviews) Sold : Login>>